Zimmer Biomet Holdings, INC Form 4 insider transactions

Zimmer Biomet Holdings, Inc. CFO Suketu Upadhyay reported the vesting of 10,632 performance-based Restricted Stock Units and the subsequent withholding of shares for tax obligations.

Zimmer Biomet Holdings, Inc.'s Executive VP and CFO, Suketu Upadhyay, earned 10,632 performance-based Restricted Stock Units, vesting on November 10, 2025.

Zimmer Biomet Holdings, Inc. Director Louis Shapiro acquired 140.163 phantom stock units as part of a deferred compensation plan.

Zimmer Biomet Holdings, Inc. Director Devdatt Kurdikar increased his beneficial ownership of phantom stock units through the company's deferred compensation plan.

Zimmer Biomet Holdings, Inc. Director Sreelakshmi Kolli accrued 159.276 phantom stock units, increasing her beneficial ownership to 5,393.594 units.

Zimmer Biomet Holdings Director Maria Teresa Hilado accrued 344.036 phantom stock units under the company's deferred compensation plan.

Zimmer Biomet Holdings, Inc. Director Arthur J. Higgins acquired 280.326 phantom stock units, increasing his beneficial ownership to 35,577.223 units.

Zimmer Biomet Holdings, Inc. Director Robert Hagemann acquired 280.326 phantom stock units, increasing his total beneficial ownership to 31,207.57 units.

Zimmer Biomet Director Michael J. Farrell acquired 382.263 phantom stock units as part of his deferred compensation plan, increasing his total beneficial ownership to 17,318.948 units.

Sang Yi, Group President, Asia Pacific at Zimmer Biomet Holdings, Inc., reported the sale of 1,200 shares of common stock at $103.585 per share under a pre-arranged trading plan.

Lori Winkler, SVP and CHRO of Zimmer Biomet Holdings, Inc., executed a pre-planned sale of 1,500 common shares on September 8, 2025.

Zimmer Biomet's VP, Controller, and CAO, Paul A. Stellato, reported the vesting of restricted stock units and subsequent tax-related share disposition.

Zimmer Biomet Holdings, Inc. SVP and CHRO Lori Winkler sold 1,500 shares of common stock for $102.49 per share in a pre-planned transaction.

Zimmer Biomet Holdings, Inc. granted 29,870 restricted stock units to Kevin R. Thornal, Group President of Global Business, vesting over three years.

Zimmer Biomet Holdings, Inc. Group President, EMEA, Wilfred van Zuilen, reported the vesting of 2,631 restricted stock units and the subsequent disposition of 692 shares to cover tax obligations.

Zimmer Biomet Holdings, Inc. Director Arthur J. Higgins reported the acquisition of 301.833 phantom stock units as part of his deferred compensation plan, increasing his beneficial ownership of derivative securities to 35,206.217.

Zimmer Biomet Holdings, Inc. Director Louis Shapiro has accrued 150.916 additional phantom stock units under the company's deferred compensation plan, bringing his total beneficial ownership to 2,197.03 units.

Zimmer Biomet Holdings, Inc. Director Michael J. Farrell has acquired 466.469 phantom stock units as part of the company's non-employee director deferred compensation plan.

Zimmer Biomet Holdings, Inc. Director Robert Hagemann has accrued 370.431 phantom stock units valued at $91.11 per unit, increasing his beneficial ownership to 30,848.064 units.

Maria Teresa Hilado, a Director at Zimmer Biomet Holdings, Inc., acquired 370.431 phantom stock units on June 30, 2025, as part of her deferred compensation plan.

Syed A. Jafry, a Director at Zimmer Biomet Holdings, Inc., acquired 178.355 phantom stock units on June 30, 2025, increasing his beneficial ownership to 7,153.79 units as part of a deferred compensation plan.

Zimmer Biomet Holdings, Inc. Director Sreelakshmi Kolli acquired 171.496 phantom stock units as part of a deferred compensation plan, increasing her beneficial ownership to 5,221.199 units.

Zimmer Biomet Holdings, Inc. Director Devdatt Kurdikar has accrued an additional 150.916 phantom stock units under the company's deferred compensation plan, increasing his total beneficial ownership to 1,470.296 units.

Sang Yi, Group President of Asia Pacific at Zimmer Biomet Holdings, Inc., reported the sale of 800 shares of company common stock for approximately $74,011.20.

Sang Yi, Group President of Asia Pacific at Zimmer Biomet Holdings, Inc., reported the sale of 1,000 shares of common stock for $95 per share.

Zimmer Biomet Holdings, Inc.'s VP, Controller & CAO, Paul A. Stellato, reported the vesting of restricted stock units and subsequent stock transactions, including shares withheld for tax obligations.

Zimmer Biomet Holdings, Inc. Director Michael J. Farrell reported the acquisition of 810.46 phantom stock units and 1,404.798 restricted stock units as part of his compensation.

Zimmer Biomet Holdings, Inc. Director Maria Teresa Hilado reported the acquisition of 810.46 phantom stock units and 1,404.798 restricted stock units on May 29, 2025, increasing her beneficial ownership in the company.

Zimmer Biomet Holdings, Inc. Director Devdatt Kurdikar acquired 810.46 phantom stock units and 1,404.798 restricted stock units on May 29, 2025, aligning his interests with shareholders.

Zimmer Biomet Holdings, Inc. Director Sreelakshmi Kolli acquired 810.46 phantom stock units and 1,404.798 restricted stock units on May 29, 2025, as part of the company's deferred compensation and equity plans.